Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of M605110 for axillary osmidrosis
jRCT2031220072Phase 2Active, not recruiting
- Sponsor
- Maruho Co., Ltd.
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in axillary bromhidrosis comparing M605110 with Placebo (2 arms). Primary endpoints: Axillary odor scores and NRS for axillary odor. Started May 2022; status: active, not recruiting.
02
Drugs
M605110
03
Conditions
axillary bromhidrosis
Beyond the preview
Go deeper on jRCT2031220072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220072.